Literature DB >> 33176566

Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life.

Gabriela Medina1, Erik Antonio Cimé Aké2, Olga Vera-Lastra2, Miguel Ángel Saavedra3, María Del Pilar Cruz-Domínguez4, Mary-Carmen Amigo5, Luis J Jara6.   

Abstract

BACKGROUND: Consequences of organ damage in primary antiphospholipid syndrome (PAPS) are diverse, our aim was to determine organ damage over time and the correlation of organ damage accrual with health-related quality of life (HRQoL) in PAPS.
METHODS: First phase: retrospective cohort applying Damage Index for Antiphospholipid Syndrome (DIAPS) at 1, 5, 10, 20 years, or longer since diagnosis. Second phase: cross-sectional study, assessing HRQoL by the Medical Outcomes Study Short Form 36 (SF-36), and organ damage accrual. Descriptive statistics and Spearman correlation coefficient were used.
RESULTS: Sixty-seven patients were included, mean follow-up:15 years. Deep vein thrombosis prevailed (71.6%), pulmonary embolism (35.8%) and stroke (32.8%). Organ damage was found in 98.5%, with a cumulative DIAPS value of 3, with greater involvement in the neuropsychiatric and peripheral vascular domains. Regarding HRQoL, deterioration in the physical component summary (PCS) was found in 89.6%. Organ damage accrual correlated inversely and significantly with all the SF-36 domains, mainly with the total score and PCS. Body pain and PCS correlated the most (rho = -0.503, rho = -0.475).
CONCLUSIONS: Organ damage accrual impaired HRQoL in PAPS. Secondary thromboprophylxis through adequate systemic management and control of cardiovascular risk factors are necessary to prevent further impairment.

Entities:  

Keywords:  Damage Index for Antiphospholipid Syndrome; Primary antiphospholipid syndrome; health related quality of life; neuropsychiatric damage; organ damage accrual

Year:  2020        PMID: 33176566     DOI: 10.1177/0961203320970651

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  1 in total

1.  Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series.

Authors:  Jacqueline A Madison; Kelsey Gockman; Claire Hoy; Ajay Tambralli; Yu Zuo; Jason S Knight
Journal:  Pediatr Rheumatol Online J       Date:  2022-02-23       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.